ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

TGTX TG Therapeutics Inc

16,01
-0,41 (-2,50%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
TG Therapeutics Inc TGTX NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,41 -2,50% 16,01 01:59:49
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
16,75 15,96 17,00 16,19 16,42
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
01.5.202413:00GLOBETG Therapeutics Provides Business Update and Reports First..
30.4.202422:55GLOBETG Therapeutics to Host Conference Call on First Quarter..
18.4.202413:30GLOBETG Therapeutics Announces Additional Data Presentations for..
18.4.202413:00GLOBETG Therapeutics Awarded National Contract by the Department..
15.4.202413:30GLOBETG Therapeutics Announces Presentation of Data for BRIUMVI®..
08.3.202413:30GLOBETG Therapeutics Announces Schedule of Data Presentations for..
01.3.202413:30GLOBETG Therapeutics Announces Presentation of Data for BRIUMVI®..
29.2.202423:23EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
28.2.202413:24EDGAR2Form 8-K - Current report
28.2.202413:00GLOBETG Therapeutics Provides Business Update and Reports Fourth..
27.2.202413:30GLOBETG Therapeutics Announces Issuance of Additional Patents for..
26.2.202413:00GLOBETG Therapeutics Announces European Launch of BRIUMVI®..
23.2.202413:30GLOBETG Therapeutics to Host Conference Call on Fourth Quarter..
20.2.202413:30GLOBETG Therapeutics Announces Schedule of Data Presentations for..
15.2.202403:53EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
14.2.202421:30EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
26.1.202422:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
10.1.202413:37EDGAR2Form 8-K - Current report
10.1.202413:00GLOBETG Therapeutics Provides Preliminary Fourth Quarter and Full..
09.1.202415:20APSBiotech Massively Bid Up Before Opening Bell
09.1.202413:00GLOBETG Therapeutics Announces Global License Agreement with..
09.1.202400:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.1.202400:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.1.202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.1.202417:02EDGAR2Form 144 - Report of proposed sale of securities
05.1.202413:30GLOBETG Therapeutics to Participate in the 42nd Annual J.P...
03.1.202422:46EDGAR2Form 144 - Report of proposed sale of securities
27.11.202313:30GLOBETG Therapeutics to Participate in the 6th Annual Evercore..
06.11.202323:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03.11.202312:30GLOBETG Therapeutics to Participate in the 5th Annual Guggenheim..
01.11.202312:33EDGAR2Form 8-K - Current report
01.11.202312:30GLOBETG Therapeutics Provides Business Update and Reports Third..
30.10.202312:30GLOBETG Therapeutics to Host Conference Call on Third Quarter..
12.10.202317:00GLOBETG Therapeutics Announces Presentation of Data for BRIUMVI..
11.10.202316:30GLOBETG Therapeutics Announces Presentation of Data for BRIUMVI..
02.10.202313:30GLOBETG Therapeutics Announces Schedule of Data Presentations for..
29.9.202323:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.9.202313:30GLOBETG Therapeutics to Participate in the 2023 Cantor Global..
07.9.202313:30GLOBETG Therapeutics to Participate in the H.C. Wainwright 25th..
14.8.202315:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.8.202322:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01.8.202313:29EDGAR2Form 8-K - Current report
01.8.202313:15GLOBETG Therapeutics Provides Business Update and Reports Second..
01.8.202313:00GLOBETG Therapeutics and Neuraxpharm Announce Ex-US..
31.7.202314:30GLOBETG Therapeutics to Host Conference Call on Second Quarter..
05.6.202313:30GLOBETG Therapeutics to Participate in the 2023 Jefferies..
02.6.202315:15GLOBETG Therapeutics Announces Presentation of Data from the..
01.6.202315:15GLOBETG Therapeutics Announces European Commission Approval for..
31.5.202313:30GLOBETG Therapeutics Announces Data from the ULTIMATE I & II..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock